$16.28

0.05 (0.31%)

10/15/2008 4:00 PM

Matrixx Initiatives, Inc. (MTXX)

CAPS Rating:

The Company develops, produces, markets and sells innovative, over-the-counter healthcare products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating MTXX

Add Stock to Watchlist

What the Community Thinks

Total Members

140 Outperforms

4 Underperforms

All-Stars

26 Outperforms

1 Underperforms

Wall Street

4 Outperforms

0 Underperforms

Members bullish on MTXX are also bullish on:

Members bearish on MTXX are also bearish on:

Ticker Tags

Micro Cap (4824), Drug Delivery (22)
Suggest a tag

Matrixx Initiatives, Inc. At A Glance

Current Price:	$16.28
Last Trade Time:	10/15/2008 4:00 PM
Open:	$16.04
Previous Close:	$16.23
Daily Range:	$15.47 - $16.53
52-Week Range:	$10.17 - $19.95
Volume:	51,712
Market Cap:	$156.47M
P/E Ratio:	17.27
Compare Our Special Broker Offers!

Stock Trends

MTXX VS S&P 500 (SPY)

News & Discussion Boards

Sorry no news articles available for MTXX.

Top Bull Pitch

Recs

2 Matrixx Initiatives, Inc. (MTXX)

Avatar Madmykl (27.97) Submitted: 12/02/07 7:28 AM

Their Zicam product has good potential. As a physician I can read their research a little more deeply and the research appears okay... that is, there IS an effect with the product and the effect is substantial. Even though they talk about it being a homeoptathic remedy I suspect that the zinc itse...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 18 : 1 2 3 4 Next »

Recs 0 (MTXX) EclecticRecluse (75.83) Submitted: 10/09/08 8:32 AM : Start Price: $15.23 MTXX Score: 16.52 Improving Professional Opinion Report this Post Replies: 0 \| Reply Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (MTXX) mrsudbury (34.82) Submitted: 6/14/08 7:34 PM : Start Price: $16.66 MTXX Score: 31.67 on my watchlist for healthcare microcap stocks Report this Post Replies: 0 \| Reply Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (MTXX) kristm (99.86) Submitted: 6/07/08 2:59 PM : Start Price: $16.51 MTXX Score: 32.93 5-star pick, micro-cap with a lot of room for growth. Decent P/E ratio, sells a popular and effective cold medication. Will keep growing or very possibly get bought out by a larger competitor. Report this Post Replies: 0 \| Reply Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (MTXX) Deandra88 (41.18) Submitted: 4/29/08 4:27 PM : Start Price: $13.64 MTXX Score: 54.84 With the double failure to produce enough flu vaccine and produce the right strain of vaccine in the last two years it is inevitable that consumer confidence will focus on drugs with a concentration on the over-the-counter homeopathic, variety. Their products are flying off the shelf in Duane Reade in NY, and I'm doing hands on research of their product placements in this popular drug store chain and other chains, and I'm happy to see their placement is prime eye-level shelving, with orientation toward the front of the store. On a personal level, I am greatly impressed with the results of preventing a minor cold from changing into a major one. My overall rational is that with their commercials and homeopathy being on the rise due to many conventional healthcare failures, an affordable share price and positive consumer reviews, this is a company that could prove attractive to a buy-out by a larger pharmaceutical company looking to grab some market share. I consider this a good value stock, and I've bought shares at $13.46. Report this Post Replies: 0 \| Reply Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (MTXX) GCBECKWITH (< 20) Submitted: 3/24/08 1:26 PM : Start Price: $15.60 MTXX Score: 37.96 Matrixx Initiatives, Inc. makers of Zicam, specializes in over-the-counter medications and cold remedies. With the healthcare costs continuing to rise, I believe the over-the-counter markets are going to boom, epecially if the pessimistic outlook of companies offering less healthcare benefits turn out to be true. I already know people who opt to try over-the-counter medications instead of going to the Doctor because their co-pay is more than they can afford. Report this Post Replies: 0 \| Reply Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 18 : 1 2 3 4 Next »

Wall Street

Results 1 - 4 of 4

picks per page. CHANGE

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackRothCapital	47.55	10/05/06		NS	$20.06	-18.84%	-33.27%	+14.42
	TrackFirstAlbany	73.91	10/03/06		NS	$19.70	-17.36%	-32.25%	+14.89
	TrackRyanBeck	74.53	09/25/06		NS	$16.98	-4.12%	-31.66%	+27.54
	TrackJimCramer	83.10	08/24/06		3W	$16.43	-0.91%	-30.91%	+30.00

Results 1 - 4 of 4

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.